跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Fresenius Kabi Deutschland Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 21, 2023
Approval ID
2be3fdf2f92e4e4b
Company
Fresenius Kabi Deutschland Gmbh
Type
Standard
Approval Details
Approval Id
2be3fdf2f92e4e4b
Drug Cima Aemps Name
TYENNE 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1231754001
Holder Company Name
Fresenius Kabi Deutschland Gmbh
Marketing Company Name
Fresenius Kabi España, S.A.U.
Holder Company Detail Path
/organization/fresenius-kabi-deutschland-gmbh
Authorization Date
2023-09-21
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
20 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Fresenius Kabi Deutschland Gmbh
Company Detail Path
/organization/fresenius-kabi-deutschland-gmbh
Company Information
Pharmaceutical Company Name
Fresenius Kabi Deutschland Gmbh
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Website
http://www.fresenius-kabi.com
Active Ingredients
TOCILIZUMAB
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 21, 2023
Approval ID
2be3fdf2f92e4e4b
Type
Standard
Back to CIMA-AEMPS Approvals